Decentralized Clinical Trials Market: Pharma Trends & Growth Forecast | Keyplayers are Curebase, Castor, IQVIA Inc., Medable Inc.among others

Decentralized Clinical Trials Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing on new opportunities in today's rapidly evolving global landscape.

The Decentralized Clinical Trials Market reached US$ 5.39 billion in 2023 and is expected to reach US$ 9.27 billion by 2031, growing at a CAGR of 7.1% during the forecast period 2024-2031.

Request a Premium Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/decentralized-clinical-trials-market?sv

Market opportunities and Growth Drivers:

Advancements in digital health technologies such as wearables, telemedicine, and AI are driving the decentralized clinical trials market by enabling real-time data collection, improved patient monitoring, and greater trial efficiency. Significant growth opportunities lie in the expanding adoption of remote monitoring and AI-driven trial management, particularly across emerging markets seeking scalable and patient-centric solutions.

Decentralized Clinical Trials Market Recent Development:

In October 2024, Adaptive Research announced its participation in groundbreaking decentralized clinical trials for Parkinsons' Disease sponsored by PhotoPharmics Inc. California Movement Disorders Center, part of Adaptive Research's network, will serve as a site for PhotoPharmics' LIGHT-PD trial, testing the efficacy of Celeste Specialized Phototherapy in treating Parkinson's symptoms.

In August 2024, Walgreens and the Biomedical Advanced Research and Development Authority (BARDA), cleared a strategic partnership to increase innovation in decentralized clinical trials as part of the Decentralized Clinical Operations for Healthcare and Research (D-COHRe) program. The program is designed to strengthen U.S. decentralized clinical trials capabilities to support the development of U.S. Food and Drug Administration (FDA)-regulated products, enhance clinical innovation to execute more efficient and relevant clinical research and evaluate other medical countermeasures in real-world environments that may be used in a public health emergency.

List of the Key Players in the Decentralized Clinical Trials Market:

ICON plc, Parexel International Corporation, Laboratory Corporation of America Holdings, Medpace, Inc., Science 37, THREAD, Inc., Curebase, Castor, IQVIA Inc., Medable Inc. and among others.

Assessing the Effects of U.S. Tariffs on the Decentralized Clinical Trials Market

The U.S. tariff war is reshaping how businesses analyze trends and make strategic decisions. As tariffs drive up costs and disrupt supply chains, companies are increasingly focused on understanding consumer behavior, identifying new sourcing opportunities, and adjusting their operations to remain competitive. The ongoing uncertainty has created a stronger demand for timely insights and data-driven strategies to navigate shifting trade dynamics and economic pressures.

Research Process:

Both primary and secondary data sources have been used in the global Decentralized Clinical Trials Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/decentralized-clinical-trials-market?sv

Segment Covered in the Decentralized Clinical Trials Market:

By Study Type - Interventional Trials, Observational Trials, Expanded Access Trials, Others

By Component - Software Solutions, Hardware Solutions, Smartphones and Tablets, Wearable Devices, Others

By Therapeutic Area - Oncology, Cardiovascular Diseases, Infectious Diseases, Respiratory Diseases, Neurology, Rare Diseases, Metabolic Disorders, Others

By End-User - Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes, Others

Regional Analysis for Decentralized Clinical Trials Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

People Also Ask:

Most Frequently Asked Questions in the Decentralized Clinical Trials Market Research Industry:

➠ What are the global figures for sales, production, consumption, imports, and exports in the Decentralized Clinical Trials market?

➠ Who are the top manufacturers in the global Decentralized Clinical Trials industry, and what is their current status in terms of production capacity, output, sales performance, pricing structure, cost analysis, profit margins, and overall revenue?

➠ What key opportunities are available for vendors in the Decentralized Clinical Trials market, and what challenges are they likely to encounter?

➠ Which application areas, end-user segments, or product types are projected to experience significant growth, and how is the market share distributed among them?

➠ What are the major drivers and barriers influencing the growth trajectory of the Decentralized Clinical Trials market?

➠ What are the primary sales, marketing, and distribution strategies used across the global Decentralized Clinical Trials industry landscape?

Browse More Reports: https://www.datamintelligence.com/research-report/decentralized-clinical-trials-market?sv

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.